Urological research, Malmö
131 – 140 of 183
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer
(
- Contribution to journal › Article
-
Mark
Active surveillance vs radical prostatectomy.
(
- Contribution to journal › Article
-
Mark
Functional in vitro characterisation of the androgen receptor GGN polymorphism.
(
- Contribution to journal › Article
-
Mark
Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.
(
- Contribution to journal › Article
-
Mark
The continuing role of PSA in the detection and management of prostate cancer
(
- Contribution to journal › Article
-
Mark
Adjuvant radiotherapy after radical prostatectomy
(
- Contribution to journal › Article
- 2006
-
Mark
Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer
(
- Contribution to journal › Article
-
Mark
Hormone therapy: Improving therapy decisions and monitoring
(
- Contribution to journal › Article
-
Mark
The role of finasteride in the management of BPH and in the prevention of prostate cancer - Introduction
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The role of PSA kinetics in the management of prostate cancer
(
- Contribution to journal › Article